BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin A, Qi C, Wei T, Li M, Cheng Q, Liu Z, Luo P, Zhang J. CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancer. Brief Bioinform 2022:bbac129. [PMID: 35395670 DOI: 10.1093/bib/bbac129] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu CJ, Hu FF, Xie GY, Miao YR, Li XW, Zeng Y, Guo AY. GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief Bioinform 2023;24:bbac558. [PMID: 36549921 DOI: 10.1093/bib/bbac558] [Reference Citation Analysis]
2 Xu Q, Altrock E, Schmitt N, Streuer A, Rapp F, Nowak V, Obländer J, Weimer N, Palme I, Göl M, Hofmann WK, Nowak D, Riabov V. In Silico Pan-Cancer Analysis Reveals Prognostic Role of the Erythroferrone (ERFE) Gene in Human Malignancies. Int J Mol Sci 2023;24. [PMID: 36675239 DOI: 10.3390/ijms24021725] [Reference Citation Analysis]
3 Liu M, Fang X, Wang H, Ji R, Guo Q, Chen Z, Ren Q, Wang Y, Zhou Y. Characterization of lipid droplet metabolism patterns identified prognosis and tumor microenvironment infiltration in gastric cancer. Front Oncol 2022;12:1038932. [PMID: 36713557 DOI: 10.3389/fonc.2022.1038932] [Reference Citation Analysis]
4 Liu Q, Liu YY, Chen XM, Tao BY, Chen K, Li WM, Xu CT, Shi Y, Li H, Liu HR. KIF5A upregulation in hepatocellular carcinoma: A novel prognostic biomarker associated with unique tumor microenvironment status. Front Oncol 2022;12:1071722. [PMID: 36686769 DOI: 10.3389/fonc.2022.1071722] [Reference Citation Analysis]
5 Xie W, Cheng J, Hong Z, Cai W, Zhuo H, Hou J, Lin L, Wei X, Wang K, Chen X, Song Y, Wang Z, Cai J. Multi-Transcriptomic Analysis Reveals the Heterogeneity and Tumor-Promoting Role of SPP1/CD44-Mediated Intratumoral Crosstalk in Gastric Cancer. Cancers (Basel) 2022;15. [PMID: 36612160 DOI: 10.3390/cancers15010164] [Reference Citation Analysis]
6 Wang W, Hua S, Li J, Zhao J, Zhang Y, Jiang J, Han B. Tumour microenvironment landscape and immunotherapy response in bladder cancer decoded by stromal MOXD1 based on copper-related genes signature. Front Oncol 2022;12:1081091. [PMID: 36620542 DOI: 10.3389/fonc.2022.1081091] [Reference Citation Analysis]
7 Wang G, Miao C, Mo L, Kahlert UD, Wu J, Ou M, Huang R, Feng R, Pang W, Shi W. MYCBP2 expression correlated with inflammatory cell infiltration and prognosis immunotherapy in thyroid cancer patients. Front Immunol 2022;13:1048503. [PMID: 36582246 DOI: 10.3389/fimmu.2022.1048503] [Reference Citation Analysis]
8 Li W, Xu N, Meng X, Yuan H, Yu T, Miao Q, Yang H, Hai B, Xiao W, Zhang X. SLC17A9-PTHLH-EMT axis promotes proliferation and invasion of clear renal cell carcinoma. iScience 2023;26:105764. [PMID: 36590170 DOI: 10.1016/j.isci.2022.105764] [Reference Citation Analysis]
9 Wu L, Sun S, Qu F, Sun M, Liu X, Sun Q, Cheng L, Zheng Y, Su G. CXCL9 influences the tumor immune microenvironment by stimulating JAK/STAT pathway in triple-negative breast cancer. Cancer Immunol Immunother 2022. [DOI: 10.1007/s00262-022-03343-w] [Reference Citation Analysis]
10 Li C, Zhang L, Xu Y, Chai D, Nan S, Qiu Z, Wang W, Deng W. The Prognostic Significance and Potential Mechanism of Prolyl 3-Hydroxylase 1 in Hepatocellular Carcinoma. Journal of Oncology 2022;2022:1-24. [DOI: 10.1155/2022/7854297] [Reference Citation Analysis]
11 Zhang W, Cao W, Tong Z, Jin Q, Jiang X, Yang Y, Yao H, Chen G, Gao W, Zhu Y, Zhou S. Identification and validation of a novel necroptosis-related prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma. Front Oncol 2022;12:1011000. [DOI: 10.3389/fonc.2022.1011000] [Reference Citation Analysis]
12 Ren X, Liu J, Wang R, Liu X, Ma X, Lu Z, Hu Z, Zheng M, Ma J, Li J. Exploring the oncogenic roles of LINC00857 in pan-cancer. Front Pharmacol 2022;13:996686. [DOI: 10.3389/fphar.2022.996686] [Reference Citation Analysis]
13 Dang Q, Liu Z, Liu Y, Wang W, Yuan W, Sun Z, Liu L, Wang C. LncRNA profiles from Notch signaling: Implications for clinical management and tumor microenvironment of colorectal cancer. Front Immunol 2022;13:953405. [DOI: 10.3389/fimmu.2022.953405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Mou W, Zhu L, Yang T, Lin A, Lyu Q, Guo L, Liu Z, Cheng Q, Zhang J, Luo P. Relationship between ATOH1 and tumor microenvironment in colon adenocarcinoma patients with different microsatellite instability status. Cancer Cell Int 2022;22:229. [PMID: 35836254 DOI: 10.1186/s12935-022-02651-6] [Reference Citation Analysis]
15 Lin A, Gu T, Hu X, Zhang J, Luo P, Tang B. Comprehensive Analysis Identifies PI3K/Akt Pathway Alternations as an Immune-Related Prognostic Biomarker in Colon Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitor Treatment. Journal of Immunology Research 2022;2022:1-14. [DOI: 10.1155/2022/8179799] [Reference Citation Analysis]
16 Lin Y, Liao X, Zhang Y, Wu G, Ye J, Luo S, He X, Luo M, Xie M, Zhang J, Li Q, Huang Y, Liao S, Li Y, Liang R. Homologous Recombination Pathway Alternation Predicts Prognosis of Colorectal Cancer With Chemotherapy. Front Pharmacol 2022;13:920939. [DOI: 10.3389/fphar.2022.920939] [Reference Citation Analysis]